show codes show debug x
`` `` `` `` `` `` " id="task-application">Task id=task-application fullUrl=(none)
Code: id=(none) fullUrl=(none)Variation Type IB [(100000155692)] (https://spor.ema.europa.eu/v1/lists/100000155688)
Identifier: EMEA/H/C/xxxx/WS/2019 (http://ema.europa.eu/fhir/procedureIdentifierNumber)
Status: requested
Intent: order
Date: Next Production Run/Next Printing - false
Task id=variation-1 fullUrl=(none)
Code: B.I.d.1.a.4 - QUALITY CHANGES - ACTIVE SUBSTANCE - Stability - Change in the re-test period/storage period or storage conditions of the active substance where no Ph. Eur. Certificate of Suitability covering the retest period is part of the approved dossier - Re-test period/storage period - [(B.I.d.1.a.4)] (https://spor.ema.europa.eu/v1/lists/100000152091-todo-scope-type)
Status: requested
Intent: order
Input
Type: Procedure Type [(100000000888)] (https://spor.ema.europa.eu/v1/lists/example/procedure-detail-type)
Value: IB [(typeIB)] (https://spor.ema.europa.eu/v1/lists/100000155688-temp)
Input
Type: Procedure Type Applicable [(100000000889)] (https://spor.ema.europa.eu/v1/lists/example/procedure-detail-type)
Value: IB [(typeIBapplicable)] (https://spor.ema.europa.eu/v1/lists/100000145688-temp)
Input
Type: Procedure Type Applicable [(100000000889)] (https://spor.ema.europa.eu/v1/lists/example/procedure-detail-type)
Value: documentations [(documentationsapplicable)] (https://spor.ema.europa.eu/v1/lists/100000145688-temp)
Input
Type: Copy of approved specifications of the active substance. [(exampleDocumentationCode)] (https://spor.ema.europa.eu/v1/lists/200000003964)
Value: (no text)
Condition Applies: true
Input
Type: Confirmation that stability studies have been done to the currently approved protocol. The studies must show that the agreed relevant specifications are still met. [(exampleDocumentationCode)] (https://spor.ema.europa.eu/v1/lists/200000003964)
Value: (no text)
Condition Applies: true
Input
Type: Amendment of the relevant section(s) of the dossier (presented in the EU-CTD format or NTA volume 6B format for veterinary products, as appropriate). This must contain results of appropriate real time stability studies, conducted in accordance with the relevant stability guidelines on at least two pilot or production scale batches of the active substance in the authorised packaging material and covering the duration of the requested retest period or requested storage conditions. [(exampleDocumentationCode)] (https://spor.ema.europa.eu/v1/lists/200000003964)
Value: (no text)
Condition Applies: true
Input
Type: Article 5 [(exampleArticle5Code)] (https://spor.ema.europa.eu/v1/lists/900000003554-dummy)
Value: true
Focus: Infanrix hexa (MedicinalProductDefinition[id=variationProduct-1-1-1])
Focus: INFANRIX-IPV+HIB (MedicinalProductDefinition[id=variationProduct-2-1-1])
Input
Type: Grouping details [(grouping-code-tbc)] (https://spor.ema.europa.eu/v1/lists/example/procedure-detail-type)
Value: id=(none) fullUrl=(none)Single Regulatory Activity [(100000155554)] (https://spor.ema.europa.eu/v1/lists/100000155553)
Input
Type: Regulatory Activity subject to a Worksharing Agreement [(100000155556)] (https://spor.ema.europa.eu/v1/lists/100000155553)
Value: true
Input
Type: Change concern [(change-concern)] (https://spor.ema.europa.eu/v1/lists/example/variation-parameter-tbc)
Value: id=(none) fullUrl=(none)Quality [(Quality)] (https://spor.ema.europa.eu/v1/lists/example/change-concern-type-tbc)
Input
Type: Domain [(100000000777)] (https://spor.ema.europa.eu/v1/lists/example/procedure-detail-type)
Value: id=(none) fullUrl=(none)Human use [(100000000012)] (https://spor.ema.europa.eu/v1/lists/100000000004)
Input
Type: Procedure Type [(100000000888)] (https://spor.ema.europa.eu/v1/lists/example/procedure-detail-type)
Value: id=(none) fullUrl=(none)Variation Type IB [(100000155692)] (https://spor.ema.europa.eu/v1/lists/100000155688)
Input
Type: Scope [(100000000999-example)] (https://spor.ema.europa.eu/v1/lists/example/procedure-detail-type)
Value: Scope of the changeWith this application, the Company is seeking approval for the shelf-life extension of " for final confirmation on the acceptability of worksharing for this submission.
Input
Type: Other Applications [(100000000999-example)] (https://spor.ema.europa.eu/v1/lists/example/procedure-detail-type)
Value: N/A for worksharing
Input
Type: noOtherChanges [(100000002345-temp-noOtherChanges)] (https://spor.ema.europa.eu/v1/lists/example/procedure-detail-type)
Value: true
Input
Type: conditionsSet [(100000002345-temp-conditionsSet)] (https://spor.ema.europa.eu/v1/lists/example/procedure-detail-type)
Value: true
Input
Type: nationalFees [(100000002345-temp-nationalFees)] (https://spor.ema.europa.eu/v1/lists/example/procedure-detail-type)
Value: true
Input
Type: submitted [(100000002345-temp-submitted)] (https://spor.ema.europa.eu/v1/lists/example/procedure-detail-type)
Value: true
Input
Type: sharing [(100000002345-temp-sharing)] (https://spor.ema.europa.eu/v1/lists/example/procedure-detail-type)
Value: true
For
Finnish Medicines Agency LOC-100000014 (https://spor.ema.europa.eu/v1/locations)
Requested by
Organization id=applicant-org-id fullUrl=(none)
Identifier: ORG-100003920 (https://spor.ema.europa.eu/v1/organizationsTODO)
Name: Finnish Medicines Agency
email: applicant@email.com
Phone: +358(0) 10 85 21 81
Address:
Microkatu 1
Kuopio
70210
Finland (Finland [(codeTodo)] (https://spor.ema.europa.eu/v1/lists/100000000002))
Location id=(none) fullUrl=(none)
Identifier: LOC-100000014 (https://spor.ema.europa.eu/v1/locations)
Address:
European Union (European Union [(100000000390)] (https://spor.ema.europa.eu/v1/lists/100000000002))
↸arrow indicates that this points back to the parent Task rather then being linked forwards from it
Provenance (Signature) id=signature-id fullUrl=(none)
Type: Author's Signature [(1.2.840.10065.1.12.1.1)] (urn:iso-astm:E1762-95:2013)
When: 2021-01-05
By
Role id=signature-person-id fullUrl=(none) - id=(none) fullUrl=(none)Senior Manager, Global Regulatory Affairs, DTP Lifecycle [(tbc)] (https://spor.ema.europa.eu/v1/lists/100000154441)
Practitioner id=signature-practitioner-id fullUrl=(none)
Name: Ms Susi Heppa
Organization id=applicant-org-id fullUrl=(none)
Identifier: ORG-100003920 (https://spor.ema.europa.eu/v1/organizationsTODO)
Name: Finnish Medicines Agency
email: applicant@email.com
Phone: +358(0) 10 85 21 81
Address:
Microkatu 1
Kuopio
70210
Finland (Finland [(codeTodo)] (https://spor.ema.europa.eu/v1/lists/100000000002))
Location id=(none) fullUrl=(none)
Identifier: LOC-100000014 (https://spor.ema.europa.eu/v1/locations)
Address:
European Union (European Union [(100000000390)] (https://spor.ema.europa.eu/v1/lists/100000000002))
Grouping - Confirm authority to sign: true
Recorded date: 2021-01-05
Target
Resource: Task[id=task-application]
Activity: attest (http://terminology.hl7.org/CodeSystem/iso-21089-lifecycle)
Product id=variationProduct-1-1-1 fullUrl=(none)
Name: Infanrix hexa
Invented name part: Infanrix hexa
Pharmaceutical dose form name part: Powder and suspension for suspension for injection
Domain: Human use [(100000000012)] (https://spor.ema.europa.eu/v1/lists/100000000004)
↸arrow indicates that this points back to the parent MedicinalProductDefinition rather then being linked forwards from it
(unknown resource type)
which is linked to this by contained resource.id
Administrable version of product id=(none) fullUrl=(none)
Administrable Dose Form: id=(none) fullUrl=(none)Powder and suspension for suspension for injection [(100000074032)] (https://spor.ema.europa.eu/v1/lists/200000000004)
Route of Administration: ()unknown ()
↸arrow indicates that this points back to the parent MedicinalProductDefinition rather then being linked forwards from it
(unknown resource type)
which is linked to this by contained resource.id
Authorisation id=(none) fullUrl=(none)
Type: Extended Data Exclusivity/Marked Protection [(220000000077TODO-)] (https://spor.ema.europa.eu/v1/lists/220000000060)
Status: Applied [(applied)] (https://spor.ema.europa.eu/v1/lists/todoAuthorisationStatus)
Holder
Organization id=applicant-org-id fullUrl=(none)
Identifier: ORG-100003920 (https://spor.ema.europa.eu/v1/organizationsTODO)
Name: Finnish Medicines Agency
email: applicant@email.com
Phone: +358(0) 10 85 21 81
Address:
Microkatu 1
Kuopio
70210
Finland (Finland [(codeTodo)] (https://spor.ema.europa.eu/v1/lists/100000000002))
Location id=(none) fullUrl=(none)
Identifier: LOC-100000014 (https://spor.ema.europa.eu/v1/locations)
Address:
European Union (European Union [(100000000390)] (https://spor.ema.europa.eu/v1/lists/100000000002))
↸arrow indicates that this points back to the parent MedicinalProductDefinition rather then being linked forwards from it
Authorisation id=ra-red-1-blue-1-1-nationalAuthInMRP fullUrl=(none)
Type: Marketing Authorisation [(220000000061)] (https://spor.ema.europa.eu/v1/lists/220000000060)
Identifier: EU/1/00/152/001 (http://ema.europa.eu/fhir/MarketingAuthorizationNumber)
Identifier: EU/1/00/152/002 (http://ema.europa.eu/fhir/MarketingAuthorizationNumber)
Identifier: EU/1/00/152/005 (http://ema.europa.eu/fhir/MarketingAuthorizationNumber)
Identifier: EU/1/00/152/006 (http://ema.europa.eu/fhir/MarketingAuthorizationNumber)
Identifier: EU/1/00/152/021 (http://ema.europa.eu/fhir/MarketingAuthorizationNumber)
Status: Valid [(100000072099)] (https://spor.ema.europa.eu/v1/lists/100000072049)
Region: ema
Status date: 2016-02-17
Holder
GlaxoSmithKline Biologicals S.A. LOC-100000014 (https://spor.ema.europa.eu/v1/locations)
Granted by:
Health Products Regulatory Authority LOC-10000032 (https://spor.ema.europa.eu/v1/locations)
Case
Type: Mutual Recognition Procedure [(100000155061)] (https://spor.ema.europa.eu/v1/lists/100000154442)
Application N/A (http://ema.europa.eu/fhir/MRPVariationNumber)
Type: Variation Type IB [(100000155692)] (https://spor.ema.europa.eu/v1/lists/100000155688)
↸arrow indicates that this points back to the parent MedicinalProductDefinition rather then being linked forwards from it
Authorisation id=ra-red-1-blue-1-1-euAuthorisation fullUrl=(none)
Type: Marketing Authorisation [(220000000061)] (https://spor.ema.europa.eu/v1/lists/220000000060)
Identifier: EU/1/00/152/001 (http://ema.europa.eu/fhir/MarketingAuthorizationNumber)
Identifier: EU/1/00/152/002 (http://ema.europa.eu/fhir/MarketingAuthorizationNumber)
Identifier: EU/1/00/152/005 (http://ema.europa.eu/fhir/MarketingAuthorizationNumber)
Identifier: EU/1/00/152/006 (http://ema.europa.eu/fhir/MarketingAuthorizationNumber)
Identifier: EU/1/00/152/021 (http://ema.europa.eu/fhir/MarketingAuthorizationNumber)
Status: Valid [(100000072099)] (https://spor.ema.europa.eu/v1/lists/100000072049)
Region: ema
Status date: 2016-02-17
Holder
GlaxoSmithKline Biologicals S.A. LOC-100000014 (https://spor.ema.europa.eu/v1/locations)
Granted by:
Health Products Regulatory Authority LOC-10000032 (https://spor.ema.europa.eu/v1/locations)
Case
Type: Centralised Procedure [(100000155059)] (https://spor.ema.europa.eu/v1/lists/100000154442)
Application N/A (http://ema.europa.eu/fhir/MRPVariationNumber)
Type: Variation Type IB [(100000155692)] (https://spor.ema.europa.eu/v1/lists/100000155688)
↸arrow indicates that this points back to the parent MedicinalProductDefinition rather then being linked forwards from it
Authorisation id=ra-red-1-blue-1-1-nationalAuthorisation fullUrl=(none)
Type: Marketing Authorisation [(220000000061)] (https://spor.ema.europa.eu/v1/lists/220000000060)
Identifier: EU/1/00/152/001 (http://ema.europa.eu/fhir/MarketingAuthorizationNumber)
Identifier: EU/1/00/152/002 (http://ema.europa.eu/fhir/MarketingAuthorizationNumber)
Identifier: EU/1/00/152/005 (http://ema.europa.eu/fhir/MarketingAuthorizationNumber)
Identifier: EU/1/00/152/006 (http://ema.europa.eu/fhir/MarketingAuthorizationNumber)
Identifier: EU/1/00/152/021 (http://ema.europa.eu/fhir/MarketingAuthorizationNumber)
Status: Valid [(100000072099)] (https://spor.ema.europa.eu/v1/lists/100000072049)
Region: ema
Status date: 2016-02-17
Holder
GlaxoSmithKline Biologicals S.A. LOC-100000014 (https://spor.ema.europa.eu/v1/locations)
Granted by:
Health Products Regulatory Authority LOC-10000032 (https://spor.ema.europa.eu/v1/locations)
Case
Type: National Procedure [(100000155062)] (https://spor.ema.europa.eu/v1/lists/100000154442)
Application N/A (http://ema.europa.eu/fhir/MRPVariationNumber)
Type: Variation Type IB [(100000155692)] (https://spor.ema.europa.eu/v1/lists/100000155688)
↸arrow indicates that this points back to the parent MedicinalProductDefinition rather then being linked forwards from it
Provenance (Change) id=prov-id-1 fullUrl=(none)
Recorded date: 2021-01-05
Based on: B.I.d.1.a.4
Target
Resource: MedicinalProductDefinition[id=variationProduct-1-1-1]
Old data: "Please refer to "Comparison document on present and proposed""
New data: "Please refer to "Comparison document on present and proposed""
Old data:
Reference: Organization/present-contact-1-org-id, LOC-100000XXX (https://spor.ema.europa.eu/v1/locations)
New data:
Reference: Organization/proposed-contact-1-org-id, LOC-100000XXX (https://spor.ema.europa.eu/v1/locations)
Target
Resource: MedicinalProductDefinition[id=variationProduct-2-1-1]
Old data: "Please refer to "Comparison document on present and proposed""
New data: "Please refer to "Comparison document on present and proposed""
Old data:
Reference: Organization/present-contact-1-org-id, LOC-100000XXX (https://spor.ema.europa.eu/v1/locations)
New data:
Reference: Organization/proposed-contact-1-org-id, LOC-100000XXX (https://spor.ema.europa.eu/v1/locations)
Activity: UPDATE (http://terminology.hl7.org/CodeSystem/v3-DataOperation)
Agent
Organization id=applicant-org-id fullUrl=(none)
Identifier: ORG-100003920 (https://spor.ema.europa.eu/v1/organizationsTODO)
Name: Finnish Medicines Agency
email: applicant@email.com
Phone: +358(0) 10 85 21 81
Address:
Microkatu 1
Kuopio
70210
Finland (Finland [(codeTodo)] (https://spor.ema.europa.eu/v1/lists/100000000002))
Location id=(none) fullUrl=(none)
Identifier: LOC-100000014 (https://spor.ema.europa.eu/v1/locations)
Address:
European Union (European Union [(100000000390)] (https://spor.ema.europa.eu/v1/lists/100000000002))
Product id=variationProduct-2-1-1 fullUrl=(none)
Name: INFANRIX-IPV+HIB
Invented name part: INFANRIX-IPV+HIB
Pharmaceutical dose form name part: Powder and suspension for suspension for injection
Domain: Human use [(100000000012)] (https://spor.ema.europa.eu/v1/lists/100000000004)
↸arrow indicates that this points back to the parent MedicinalProductDefinition rather then being linked forwards from it
(unknown resource type)
which is linked to this by contained resource.id
Administrable version of product id=(none) fullUrl=(none)
Administrable Dose Form: id=(none) fullUrl=(none)Powder and suspension for suspension for injection [(100000074032)] (https://spor.ema.europa.eu/v1/lists/200000000004)
Route of Administration: ()unknown ()
↸arrow indicates that this points back to the parent MedicinalProductDefinition rather then being linked forwards from it
Authorisation id=ra-red-2-blue-1-1-nationalAuthInMRP fullUrl=(none)
Type: Marketing Authorisation [(220000000061)] (https://spor.ema.europa.eu/v1/lists/220000000060)
Identifier: 2-00370 (http://ema.europa.eu/fhir/MarketingAuthorizationNumber)
Status: Valid [(100000072099)] (https://spor.ema.europa.eu/v1/lists/100000072049)
Region: Austria
Status date: 2016-02-17
Holder
GlaxoSmithKline Pharma GmbH LOC-100000014 (https://spor.ema.europa.eu/v1/locations)
Granted by:
Health Products Regulatory Authority LOC-10000032 (https://spor.ema.europa.eu/v1/locations)
Case
Type: Mutual Recognition Procedure [(100000155061)] (https://spor.ema.europa.eu/v1/lists/100000154442)
Application DE/H/0145/002/WS/249 (http://ema.europa.eu/fhir/MRPVariationNumber)
Type: Variation Type IB [(100000155692)] (https://spor.ema.europa.eu/v1/lists/100000155688)
↸arrow indicates that this points back to the parent MedicinalProductDefinition rather then being linked forwards from it
Authorisation id=ra-red-2-blue-1-1-euAuthorisation fullUrl=(none)
Type: Marketing Authorisation [(220000000061)] (https://spor.ema.europa.eu/v1/lists/220000000060)
Identifier: 2-00370 (http://ema.europa.eu/fhir/MarketingAuthorizationNumber)
Status: Valid [(100000072099)] (https://spor.ema.europa.eu/v1/lists/100000072049)
Region: Austria
Status date: 2016-02-17
Holder
GlaxoSmithKline Pharma GmbH LOC-100000014 (https://spor.ema.europa.eu/v1/locations)
Granted by:
Health Products Regulatory Authority LOC-10000032 (https://spor.ema.europa.eu/v1/locations)
Case
Type: Centralised Procedure [(100000155059)] (https://spor.ema.europa.eu/v1/lists/100000154442)
Application DE/H/0145/002/WS/249 (http://ema.europa.eu/fhir/MRPVariationNumber)
Type: Variation Type IB [(100000155692)] (https://spor.ema.europa.eu/v1/lists/100000155688)
↸arrow indicates that this points back to the parent MedicinalProductDefinition rather then being linked forwards from it
Authorisation id=ra-red-2-blue-1-1-nationalAuthorisation fullUrl=(none)
Type: Marketing Authorisation [(220000000061)] (https://spor.ema.europa.eu/v1/lists/220000000060)
Identifier: 2-00370 (http://ema.europa.eu/fhir/MarketingAuthorizationNumber)
Status: Valid [(100000072099)] (https://spor.ema.europa.eu/v1/lists/100000072049)
Region: Austria
Status date: 2016-02-17
Holder
GlaxoSmithKline Pharma GmbH LOC-100000014 (https://spor.ema.europa.eu/v1/locations)
Granted by:
Health Products Regulatory Authority LOC-10000032 (https://spor.ema.europa.eu/v1/locations)
Case
Type: National Procedure [(100000155062)] (https://spor.ema.europa.eu/v1/lists/100000154442)
Application DE/H/0145/002/WS/249 (http://ema.europa.eu/fhir/MRPVariationNumber)
Type: Variation Type IB [(100000155692)] (https://spor.ema.europa.eu/v1/lists/100000155688)
↸arrow indicates that this points back to the parent MedicinalProductDefinition rather then being linked forwards from it
Provenance (Change) id=prov-id-1 fullUrl=(none)
Recorded date: 2021-01-05
Based on: B.I.d.1.a.4
Target
Resource: MedicinalProductDefinition[id=variationProduct-1-1-1]
Old data: "Please refer to "Comparison document on present and proposed""
New data: "Please refer to "Comparison document on present and proposed""
Old data:
Reference: Organization/present-contact-1-org-id, LOC-100000XXX (https://spor.ema.europa.eu/v1/locations)
New data:
Reference: Organization/proposed-contact-1-org-id, LOC-100000XXX (https://spor.ema.europa.eu/v1/locations)
Target
Resource: MedicinalProductDefinition[id=variationProduct-2-1-1]
Old data: "Please refer to "Comparison document on present and proposed""
New data: "Please refer to "Comparison document on present and proposed""
Old data:
Reference: Organization/present-contact-1-org-id, LOC-100000XXX (https://spor.ema.europa.eu/v1/locations)
New data:
Reference: Organization/proposed-contact-1-org-id, LOC-100000XXX (https://spor.ema.europa.eu/v1/locations)
Activity: UPDATE (http://terminology.hl7.org/CodeSystem/v3-DataOperation)
Agent
Organization id=applicant-org-id fullUrl=(none)
Identifier: ORG-100003920 (https://spor.ema.europa.eu/v1/organizationsTODO)
Name: Finnish Medicines Agency
email: applicant@email.com
Phone: +358(0) 10 85 21 81
Address:
Microkatu 1
Kuopio
70210
Finland (Finland [(codeTodo)] (https://spor.ema.europa.eu/v1/lists/100000000002))
Location id=(none) fullUrl=(none)
Identifier: LOC-100000014 (https://spor.ema.europa.eu/v1/locations)
Address:
European Union (European Union [(100000000390)] (https://spor.ema.europa.eu/v1/lists/100000000002))
Warning - Found 3 copies of RegulatedAuthorization EU/1/00/152/001(id=ra-red-1-blue-1-1-nationalAuthInMRP)(id=ra-red-1-blue-1-1-euAuthorisation)(id=ra-red-1-blue-1-1-nationalAuthorisation).
Warning - Found 3 copies of RegulatedAuthorization EU/1/00/152/002(id=ra-red-1-blue-1-1-nationalAuthInMRP)(id=ra-red-1-blue-1-1-euAuthorisation)(id=ra-red-1-blue-1-1-nationalAuthorisation).
Warning - Found 3 copies of RegulatedAuthorization EU/1/00/152/005(id=ra-red-1-blue-1-1-nationalAuthInMRP)(id=ra-red-1-blue-1-1-euAuthorisation)(id=ra-red-1-blue-1-1-nationalAuthorisation).
Warning - Found 3 copies of RegulatedAuthorization EU/1/00/152/006(id=ra-red-1-blue-1-1-nationalAuthInMRP)(id=ra-red-1-blue-1-1-euAuthorisation)(id=ra-red-1-blue-1-1-nationalAuthorisation).
Warning - Found 3 copies of RegulatedAuthorization EU/1/00/152/021(id=ra-red-1-blue-1-1-nationalAuthInMRP)(id=ra-red-1-blue-1-1-euAuthorisation)(id=ra-red-1-blue-1-1-nationalAuthorisation).
Warning - Found 3 copies of RegulatedAuthorization EU/1/00/152/001(id=ra-red-1-blue-1-1-nationalAuthInMRP)(id=ra-red-1-blue-1-1-euAuthorisation)(id=ra-red-1-blue-1-1-nationalAuthorisation).
Warning - Found 3 copies of RegulatedAuthorization EU/1/00/152/002(id=ra-red-1-blue-1-1-nationalAuthInMRP)(id=ra-red-1-blue-1-1-euAuthorisation)(id=ra-red-1-blue-1-1-nationalAuthorisation).
Warning - Found 3 copies of RegulatedAuthorization EU/1/00/152/005(id=ra-red-1-blue-1-1-nationalAuthInMRP)(id=ra-red-1-blue-1-1-euAuthorisation)(id=ra-red-1-blue-1-1-nationalAuthorisation).
Warning - Found 3 copies of RegulatedAuthorization EU/1/00/152/006(id=ra-red-1-blue-1-1-nationalAuthInMRP)(id=ra-red-1-blue-1-1-euAuthorisation)(id=ra-red-1-blue-1-1-nationalAuthorisation).
Warning - Found 3 copies of RegulatedAuthorization EU/1/00/152/021(id=ra-red-1-blue-1-1-nationalAuthInMRP)(id=ra-red-1-blue-1-1-euAuthorisation)(id=ra-red-1-blue-1-1-nationalAuthorisation).
Warning - Found 3 copies of RegulatedAuthorization EU/1/00/152/001(id=ra-red-1-blue-1-1-nationalAuthInMRP)(id=ra-red-1-blue-1-1-euAuthorisation)(id=ra-red-1-blue-1-1-nationalAuthorisation).
Warning - Found 3 copies of RegulatedAuthorization EU/1/00/152/002(id=ra-red-1-blue-1-1-nationalAuthInMRP)(id=ra-red-1-blue-1-1-euAuthorisation)(id=ra-red-1-blue-1-1-nationalAuthorisation).
Warning - Found 3 copies of RegulatedAuthorization EU/1/00/152/005(id=ra-red-1-blue-1-1-nationalAuthInMRP)(id=ra-red-1-blue-1-1-euAuthorisation)(id=ra-red-1-blue-1-1-nationalAuthorisation).
Warning - Found 3 copies of RegulatedAuthorization EU/1/00/152/006(id=ra-red-1-blue-1-1-nationalAuthInMRP)(id=ra-red-1-blue-1-1-euAuthorisation)(id=ra-red-1-blue-1-1-nationalAuthorisation).
Warning - Found 3 copies of RegulatedAuthorization EU/1/00/152/021(id=ra-red-1-blue-1-1-nationalAuthInMRP)(id=ra-red-1-blue-1-1-euAuthorisation)(id=ra-red-1-blue-1-1-nationalAuthorisation).
Warning - Found 3 copies of RegulatedAuthorization 2-00370(id=ra-red-2-blue-1-1-nationalAuthInMRP)(id=ra-red-2-blue-1-1-euAuthorisation)(id=ra-red-2-blue-1-1-nationalAuthorisation).
Warning - Found 3 copies of RegulatedAuthorization 2-00370(id=ra-red-2-blue-1-1-nationalAuthInMRP)(id=ra-red-2-blue-1-1-euAuthorisation)(id=ra-red-2-blue-1-1-nationalAuthorisation).
Warning - Found 3 copies of RegulatedAuthorization 2-00370(id=ra-red-2-blue-1-1-nationalAuthInMRP)(id=ra-red-2-blue-1-1-euAuthorisation)(id=ra-red-2-blue-1-1-nationalAuthorisation).